Suzhou Sepax Technologies
688758
Juneway Electronic Technology
301458
Jiujiang Defu Technology
301511
Cubic Digital Technology
300344
Ningbo Shuanglin Auto Parts
300100
CN Stock MarketDetailed Quotes
002907 Chongqing Pharscin Pharmaceutical
- 12.13
- -0.56-4.41%
Market Closed Jan 10 15:00 CST
5.07BMarket Cap80.87P/E (TTM)
12.71High12.13Low30.21KlotVolume12.67Open12.69Pre Close37.44MTurnover0.98%Turnover Ratio155.51P/E (Static)417.60MShares16.6852wk High3.06P/B3.75BFloat Cap9.7452wk Low13.96Limit Up308.89MShs Float47.54Historical High11.42Limit Down4.57%Amplitude5.60Historical Low0.09Dividend TTM12.39Avg Price17.83KlotAsk0.70%Div YieldTTM100Lot Size11.52KlotBid
Chongqing Pharscin Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 19.21%614.22M | 15.92%417.85M | 21.78%228.39M | -11.93%691.54M | -8.27%515.26M | -1.95%360.46M | -7.61%187.54M | -7.20%785.18M | -12.96%561.69M | -15.63%367.63M |
| Operating revenue | 19.21%614.22M | 15.92%417.85M | 21.78%228.39M | -11.93%691.54M | -8.27%515.26M | -1.95%360.46M | -7.61%187.54M | -7.20%785.18M | -12.96%561.69M | -15.63%367.63M |
| Other operating revenue | ---- | -9.79%5.24M | ---- | 2.23%10.7M | ---- | 13.56%5.8M | ---- | 17.50%10.47M | ---- | 38.07%5.11M |
| Total operating cost | 14.24%534.3M | 13.86%361.85M | 18.96%180.61M | -4.43%655.56M | -3.90%467.71M | 1.33%317.79M | -9.29%151.82M | -8.89%685.93M | -10.05%486.68M | -14.50%313.62M |
| Operating cost | 16.71%259.86M | 13.92%175.94M | 20.70%89.84M | -2.49%311.35M | -3.66%222.65M | -1.36%154.45M | -17.12%74.44M | -20.16%319.29M | -22.38%231.12M | -24.08%156.58M |
| Operating tax surcharges | 10.25%7.83M | 11.21%6.05M | 15.32%2.05M | -10.83%11.01M | -3.04%7.1M | 2.06%5.44M | -2.36%1.78M | 6.58%12.34M | -6.76%7.33M | -11.20%5.33M |
| Operating expense | 24.36%196.18M | 21.87%133.7M | 28.50%68.01M | -14.31%210.74M | -7.70%157.76M | 3.87%109.71M | -2.61%52.93M | -4.89%245.93M | -4.91%170.91M | -7.64%105.62M |
| Administration expense | 10.40%41.03M | 13.55%27.77M | 9.52%12.76M | 14.06%53.14M | 17.06%37.17M | 19.12%24.45M | 22.25%11.65M | 18.75%46.59M | 9.90%31.75M | 3.09%20.53M |
| Financial expense | -50.45%-9.59M | -44.11%-7.46M | -50.36%-4.7M | -398.60%-8.8M | -195.69%-6.38M | -219.40%-5.17M | -206.96%-3.13M | 59.64%2.95M | 354.21%6.66M | 35.87%4.33M |
| -Interest expense (Financial expense) | -137.56%-344.42K | -99.32%4.34K | ---- | -93.44%945.35K | -93.62%916.91K | -93.30%637.78K | -96.41%169.53K | -20.89%14.42M | 6.03%14.38M | 5.93%9.51M |
| -Interest Income (Financial expense) | -27.19%-9.33M | -28.60%-7.51M | -42.90%-4.73M | 14.67%-9.81M | 5.25%-7.34M | -12.50%-5.84M | -83.50%-3.31M | 29.91%-11.5M | 36.08%-7.74M | 10.61%-5.19M |
| Research and development | -21.08%38.99M | -10.62%25.84M | -10.65%12.64M | 32.81%78.12M | 26.98%49.4M | 36.21%28.91M | 58.41%14.15M | 40.98%58.82M | 53.39%38.91M | 24.12%21.23M |
| Credit Impairment Loss | -334.62%-3.86M | -233.83%-2.2M | -869.97%-2.91M | 147.63%1.59M | 152.39%1.65M | 191.20%1.64M | 119.22%377.77K | -802.10%-3.35M | -94.33%-3.14M | 57.86%-1.8M |
| Asset Impairment Loss | -23.04%-1.07M | -3.64%-397.15K | 75.40%-68.07K | 12.95%-1.1M | -18.26%-868.26K | -39.72%-383.19K | -309.56%-276.74K | -106.83%-1.26M | -90.11%-734.19K | 7.20%-274.25K |
| Other net revenue | 120.21%9.14M | -63.51%1.64M | 784.93%263.5K | 2.74%9.84M | -43.52%4.15M | -40.37%4.48M | 102.90%29.78K | -4.90%9.58M | 1,045.22%7.34M | 374.07%7.51M |
| Fair value change income | --437.87K | --90.1K | ---- | 127.31%3.45M | ---- | ---- | ---- | 54.02%1.52M | 183.23%1.52M | 106.26%851.65K |
| Invest income | 35.59%-3.44M | 7.81%-2.84M | 78.52%-371.71K | -96.91%-8.12M | -65.05%-5.34M | -53.05%-3.08M | -123.49%-1.73M | -78.32%-4.12M | -25.23%-3.23M | -30.54%-2.01M |
| -Including: Investment income associates | 30.55%-3.82M | 11.50%-2.87M | 80.37%-371.71K | -56.97%-8.09M | -35.59%-5.5M | -14.34%-3.24M | -52.24%-1.89M | -79.50%-5.15M | -29.19%-4.06M | -49.66%-2.83M |
| Asset deal income | ---- | ---- | ---- | --58.47K | --58.47K | --58.47K | --58.47K | ---- | ---- | ---- |
| Other revenue | 97.25%17.07M | 11.80%6.98M | 125.65%3.61M | -16.91%13.95M | -33.12%8.65M | -41.94%6.24M | 5.92%1.6M | 45.64%16.79M | 175.77%12.94M | 263.82%10.75M |
| Operating profit | 72.27%89.05M | 22.26%57.64M | 34.41%48.05M | -57.89%45.82M | -37.23%51.69M | -23.37%47.14M | 3.37%35.75M | 5.34%108.83M | -21.50%82.35M | -7.06%61.52M |
| Add:Non operating Income | 53.08%202.73K | 12.62%75.14K | 14.92%39.45K | -26.69%148.65K | -1.92%132.43K | -7.90%66.72K | -35.09%34.32K | -3.82%202.75K | -0.20%135.02K | -8.49%72.45K |
| Less:Non operating expense | 87.69%584.72K | 5,019.18%513.85K | 269.45%18.61K | 300.92%3.17M | -38.34%311.53K | -97.96%10.04K | -98.32%5.04K | 668.68%791.91K | 823.07%505.26K | 4,695.52%492.98K |
| Total profit | 72.13%88.67M | 21.19%57.2M | 34.35%48.07M | -60.46%42.8M | -37.16%51.52M | -22.75%47.2M | 4.20%35.78M | 4.66%108.24M | -21.91%81.98M | -7.79%61.1M |
| Less:Income tax cost | 109.12%14.1M | 71.03%9.99M | 35.94%7.71M | 2.61%10.1M | -26.22%6.74M | -36.03%5.84M | 13.86%5.68M | -15.46%9.84M | -41.23%9.14M | -8.67%9.13M |
| Net profit | 66.56%74.58M | 14.15%47.21M | 34.05%40.35M | -66.77%32.7M | -38.54%44.78M | -20.42%41.36M | 2.55%30.1M | 7.21%98.4M | -18.55%72.85M | -7.63%51.97M |
| Net profit from continuing operation | 66.56%74.58M | 14.15%47.21M | 34.05%40.35M | -66.77%32.7M | -38.54%44.78M | -20.42%41.36M | 2.55%30.1M | 7.21%98.4M | -18.55%72.85M | -7.63%51.97M |
| Net profit of parent company owners | 66.56%74.58M | 14.15%47.21M | 34.05%40.35M | -66.77%32.7M | -38.54%44.78M | -20.42%41.36M | 2.55%30.1M | 7.21%98.4M | -18.55%72.85M | -7.63%51.97M |
| Earning per share | ||||||||||
| Basic earning per share | 66.60%0.1786 | 14.24%0.1131 | 33.98%0.0966 | -67.92%0.0783 | -40.97%0.1072 | -23.61%0.099 | -1.50%0.0721 | 6.69%0.2441 | -18.57%0.1816 | -7.69%0.1296 |
| Diluted earning per share | 66.60%0.1786 | 14.24%0.1131 | 33.98%0.0966 | -67.92%0.0783 | -40.97%0.1072 | -23.61%0.099 | -1.50%0.0721 | 6.69%0.2441 | -18.57%0.1816 | -7.69%0.1296 |
| Other composite income | -126.68%-173.85K | -86.64%101.87K | 151.27%28.42K | -86.62%47.05K | 50.72%651.71K | 279.94%762.33K | -237.25%-55.43K | 494.10%351.73K | 1,928.70%432.4K | 616.92%200.64K |
| Other composite income of parent company owners | -126.68%-173.85K | -86.64%101.87K | 151.27%28.42K | -86.62%47.05K | 50.72%651.71K | 279.94%762.33K | -237.25%-55.43K | 494.10%351.73K | 1,928.70%432.4K | 616.92%200.64K |
| Total composite income | 63.79%74.4M | 12.33%47.32M | 34.40%40.38M | -66.84%32.75M | -38.01%45.43M | -19.26%42.12M | 2.42%30.05M | 7.70%98.75M | -18.04%73.28M | -7.21%52.17M |
| Total composite income of parent company owners | 63.79%74.4M | 12.33%47.32M | 34.40%40.38M | -66.84%32.75M | -38.01%45.43M | -19.26%42.12M | 2.42%30.05M | 7.70%98.75M | -18.04%73.28M | -7.21%52.17M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.